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Should Not Be Used for Flow
Cytometry Applications Querying
IL-4 Expression
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1 Department of Surgery-Transplant, University of Nebraska Medical Center, Omaha, NE, United States, 2 Mass
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Interleukin(IL)-4 is produced by T cells and other leukocytes and is a critical mediator
of monocyte and B cell responses. During routine flow cytometry panel validation
for the investigation of intracellular cytokines, we observed unique IL-4 expression
patterns associated with the widely available monoclonal antibody 8D4-8. Namely, IL-4
(8D4-8) expression was observed in the absence of cellular activation and enhanced
following staurosporine exposure. Mass spectrometry analysis of immunoprecipitates
from peripheral blood lymphocytes (PBL) revealed that 8D4-8 cross-reacts with the
ubiquitous cytoskeletal protein myosin-9. We confirmed these results by western
blotting immunoprecipitates, using immunofluorescence among staurosporine-treated
Caco-2 cells, and by surface-labeling PBL for 8D4-8 and myosin-9 and analyzing by flow
cytometry. Although previously reported from several independent groups, we found no
evidence to support the hypothesis that IL-4 is produced by apoptotic cells. Rather, this
appears to have been myosin-9. Our data indicate clone 8D4-8 should not be used
in the flow cytometric study of IL-4. Furthermore, our work calls for a reevaluation of
previous flow cytometric studies that have used this clone for IL-4 analysis and highlights
the importance of validation in antibody-based assays.
Keywords: interleukin-4, myosin-9, cross-reacting antibodies, 8D4-8, apoptosis, flow cytometry, IL-4
INTRODUCTION
The cytokine interleukin 4 (IL-4, b-cell stimulating factor 1) is produced by T cell subsets, mast
cells, and basophils and participates in B cell activation, immunoglobulin class switching, and
monocyte maturation and polarization (Te Velde et al., 1988; Tadmori et al., 1989; Bradding
et al., 1992; Le Gros and Erard, 1994; Mueller et al., 1994; Jung et al., 1995; Blotta et al., 1996;
Hart et al., 1999; Tangye et al., 2002). At least 3 isoforms of IL-4 are thought to exist. The
canonical sequence generates a functional protein of approximately 17 kD (Yoshizaki et al., 1983;
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Le et al., 1988; Apweiler et al., 2004). Following the discovery
of the full-length protein was the identification of a truncated
form missing exon 2 which appears to possess limited bioactivity
(Alms et al., 1996; Atamas et al., 1996). More recently, an
apoptosis-associated isoform was described (Ledru et al., 2003).
This isoform was found to be not secreted and its bioactivity has
not been identified.
The flow cytometric analysis of IL-4 expression has allowed for
the characterization of Th2-type responses in a variety of settings
(Nakayama et al., 2017). Such analyses have been enabled by
the generation and commercial availability of several monoclonal
antibodies targeting the protein. Of these, clone 8D4-8 was
originally described in 1991 from hybridomas derived from
Balb/c mice immunized with recombinant human IL-4 (Bird
et al., 1991). In this report, the IL-4 used for immunization had
been cloned and expressed in yeast and modified to prevent
glycosylation. Clone 8D4-8 was found to bind human IL-4
expressed by bacterial, fungal, and mammalian systems. One of
the earliest reports using 8D4-8 in flow cytometry was in 1995,
in a pivotal methods publication (Prussin and Metcalfe, 1995).
Currently, the clone is widely available frommultiple commercial
sources in a myriad of formats.
An unfortunate reality of any antibody-based assay is the
problem of cross-reactivity (deBruin et al., 2010; Benicky et al.,
2012; Hansson et al., 2013). This can lead to spurious results
and gross misinterpretations of biological phenomena. Here, we
describe the outcome of a recent flow cytometric panel validation
which revealed unique IL-4 expression associated with clone
8D4-8, which was not observed by 4 other monoclonal antibodies
targeting IL-4. Upon closer examination, we found that clone
8D4-8 cross-reacts with myosin-9, a ubiquitous cytoskeletal
protein (Pecci et al., 2018). This cross-reaction is associated with
cellular apoptosis, generates misleading results, and indicates
clone 8D4-8 should be avoided in flow cytometric applications
investigating IL-4 expression.
MATERIALS AND METHODS
Cells
We acquired human peripheral blood lymphocytes (PBL) from
the UNMC elutriation core facility. PBL were rested overnight
in X-VIVO-15 media (Lonza) supplemented with 2% v/v human
AB serum (MP Biomedicals), 5 pg/mL IL-2(Cell Sciences), and
20 pg/mL IL-7 (Biolegend) at 37◦C with 5% CO2 prior to
experimentation. We purchased Caco-2 cells (HTB-37) from the
ATCC. Caco-2 cells were cultured at 37◦C with 5% CO2 in
minimal essential media (MEM, Hyclone) supplemented with
20% v/v fetal bovine serum (Hyclone), 2 mM L-glutamine
(Corning), 1× non-essential amino acids (Hyclone), 1 mM
sodium pyruvate (Gibco), 500 units/mL pencillin and 500µg/mL
streptomycin (Gibco). Staurosporine (Thermo Fisher Scientific)
was used at 1 µM or stated concentrations.
Antibodies
We used the following primary antibodies: IL-4 clone 8D4-
8 (PE and unlabeled from BioLegend; BrilliantViolet 421, BD
Biosciences), IL-4 clone 3010.211 (PE, BD Biosciences), IL-
4 clone 4D9 (PE, Beckman Coulter), IL-4 clone REA895
(PE, Miltenyi), IL-4 clone MP4-25D2 (PE, BioLegend), IFN-γ
(4S.B3, PE, Biolegend), CD3 (SK7, BrilliantUltraviolet 737,
BD Biosciences and UCHT1, FITC, Biolegend), CD4 (RPA-
T4, PE-CF594, BD Biosciences), CD45RA (HI100, APC,
Biolegend), CD8 (RPA-T8, BrilliantViolet 510, BD Biosciences),
CD161 (HP-3G10, BrilliantViolet 421, BioLegend), Vα7.2 (3C10,
FITC, BioLegend), myosin-9 (EPR8965, unlabeled, AbCam),
myosin-9 (polyclonal EB09020, unlabeled, Everest Biotech),
rat IgG1 isotype (eBRG1, PE, eBioscience), mouse IgG1
isotype (MOPC-21, PE, Biolegend), and human IgG1 isotype
(QA16A12, PE, Biolegend).
Flow Cytometry
To induce cytokine production, PBL were stimulated with Cell
Stimulation Cocktail (a mixture of phorbol 12-myristate 13-
acetate (PMA), ionomycin, brefeldin A, and monensin from
eBioscience) or brefeldin A andmonensin only [protein transport
inhibitors (PTI) from Biolegend] according to manufacturers’
instructions for 5.5 h. Cells were then washed with PBS,
counted with a haemocytometer and labeled with Live/Dead
UV Blue (Thermo Fisher Scientific) according to manufacturer’s
protocol. After washing with flow cytometry staining buffer
(FCSB: 0.75% w/v BSA, 1 mM EDTA, 0.05% NaN3 in PBS),
Fc receptors were blocked with human IgG (Sigma Aldrich).
Surface antibodies were added to cells and incubated for 30 min
at 4◦C in the dark. Cells were washed, fixed with 3% PFA for
30 min at room temperature in the dark. Cell were then washed
with Permeabilization buffer (BioLegend), blocked with human,
mouse and rat IgG (Jackson Immunoresearch), then labeled with
intracellular antibodies for 30 min at room temperature in the
dark. Cells were washed with permeabilization buffer, then FCSB
before being resuspended in FCSB prior to analysis. Samples were
analyzed with a BD LSR II and data were analyzed with FlowJo
(v10 TreeStar). For Figure 2B, frequencies were normalized using
natural log transformations. They were then compared using
one-way analysis of variance (ANOVA). P values < 0.05 were
considered significant. Statistical tests and associated figures were
completed using GraphPad Prism version 6.03.
For myosin-9 and 8D4-8 co-staining, after Live/Dead
labeling cells were blocked with 10% donkey serum (Equitech)
supplemented with human and mouse IgG. PE-conjugated 8D4-
8 and unlabeled myosin-9 (EPR8965) were surface labeled
as described above. Cells were washed and incubated with
donkey anti-rabbit IgG conjugated to DyLight649 (BioLegend)
for 20 min in the dark at 4◦C. Cells were then washed, fixed, and
analyzed as above.
Western Blot
We produced protein lysates using radioimmunoprecipitation
assay (RIPA) buffer (25 mM Tris–HCl pH 7.6, 150 mM NaCl,
5mMEDTA, 1%NP-40, 1% sodiumdeoxycholate, and 0.1% SDS)
supplemented with protease inhibitor cocktail III and 0.5 mM
PMSF (Research Products International). Cellular disruption
was aided by forcing suspensions through a 27 gauge needle
repeatedly. We then spun the lysates at 21,000 × g for 10 min
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at 4◦C. We determined protein concentrations using the Pierce
Rapid Gold BCA Protein Assay kit (Thermo Fisher Scientific)
and Pierce Bovine Serum Albumin standards (Thermo Fisher
Scientific) to generate the standard curve. Lysates were diluted
into Laemlli buffer supplemented with 100 mM DTT (Research
Products International) and heated for 15 min at 65◦C. 20–35 µg
of soluble lysate was loaded per well and recombinant human
IL-4 (BioLegend) was loaded at 300 pg per well as a positive
control. Precision Plus All Blue standards (BioRad) were used
to approximate molecular weight. Proteins were separated using
SDS-PAGE with either 14 or 7.5% gels, then transferred onto
0.45 µm PVDF (Thermo Fisher Scientific) in 5% v/v MeOH
Towbin buffer overnight at 0.11 A using the Mini Trans-Blot
cell (BioRad). Following transfer, membranes were blocked for
2 h with 5% milk in 0.1% Tween 20 v/v tris-buffered saline
(TBST). Primary antibodies were diluted in 3% w/v BSA in
TBST and incubated with membranes overnight at 4◦C with
rocking. Purified 8D4-8 was used at 1 µg/mL, GAPDH at
20 ng/mL, myosin-9 (EPR8965) at 96 ng/mL, and myosin-9
(EB09020) at 500 ng/mL. Membranes were then washed
thoroughly with TBST and probed with secondary antibodies
(Jackson Immunoresearch). Horseradish peroxidase-conjugated
Donkey anti-goat, anti-rabbit, and anti-mouse IgG were used at
1:40,000, 1:100,000, and 1:100,000, respectively. SupersignalWest
Pico Plus and Supersignal West Femto Maximum Sensitivity
Chemiluminescent substrates (Thermo Fisher Scientific) were
used for detection. Membranes were exposed for 10 s to 1 min
onto autoradiography film, then developed using an Optimax
Film Processor (Protec). Films were then digitized and annotated
using a BioRad Gel Doc system. Blots were reprobed for loading
controls following washing in mild stripping buffer (0.1% w/v
SDS, 1.5%w/v glycine, 1%v/v Tween 20 pH2.2).
Immunofluorescence
Following trypsinization at subculturing, Caco-2 cells were
seeded onto Nunc LabTek Permanox chamber slides (Thermo
Fisher Scientific) and allowed to attach and expand for 2 days.
We then removed old media and replaced with fresh media
(control) or fresh media supplemented with 1 µM staurosporine
and cultured overnight. We then removed media and washed
slides gently in PBS. Cells were fixed in 3% w/v PFA for 20 min
at room temperature, washed in PBS, and then blocked in 10%
donkey serum (Equitech) with 0.1% v/v Triton X-100 (Sigma
Aldrich) for 1 h. We diluted primary antibodies in FCSB +
0.1% v/v Triton X-100 and incubated at room temperature for
2 h. Clone 8D4-8 was used at 10 µg/mL and myosin -9 clone
EPR8965 was used 500 ng/mL. Control chambers were incubated
with antibody diluent only. Following primary incubation, slides
were washed thoroughly with PBS and incubated with secondary
antibodies for 1 h at room temperature in the dark. Donkey
anti-rabbit IgG conjugated to CF568 and donkey anti-mouse
IgG conjugated to biotin (Biotium) were used at 3 µg/mL.
Slides were then washed with PBS and cultured for 30 min
with streptavidin-conjugated CF488A(Biotium) at 8 µg/mL.
Following final washing, coverslips were mounted with ProLong
Diamond Antifade Mountant with DAPI (Thermo Fisher
Scientific). Images were taken using a Zeiss Axio Imager.A2 with
an Axiocam 503 mono camera and Zen software. Images were
merged and prepared using Fiji (Schindelin et al., 2012).
Immunoprecipitation
Protein lysates from control and staurosporine-treated PBL were
prepared as described above. Lysates (1 mg in 1 mL RIPA) were
precleared by adding 1 µg ChromPure mouse IgG (Jackson
Immunoresearch) and 60 µL Protein A/G plus Agarose (Santa
Cruz Biotechnology) and rotating for 1 h at 4◦C. Agarose was
pelleted and supernatents were transferred to new tubes. 10 µg
8D4-8 was added and samples were incubated with rotation for
1 h at 4◦C after which 60 µL Protein A/G plus Agarose was
added and rotation was allowed to continue overnight. Agarose
was then pelleted and washed in 10% RIPA in PBS four times.
After the final wash, agarose was resuspended in 40 µL Laemlli
buffer with 100 mM DTT, heated as above, centrifuged, then
20 µL of immunoprecipitate was separated using SDS-PAGE.
After electrophoresis, gels were fixed overnight in 45%methanol,
10% glacial acetic acid. Fixed gels were stained with Coomassie
R-250, destained, and∼100 kD bands were excised and stored in
MilliQ water (Millipore) prior to digestion.
Mass Spectrometry
The stained protein band corresponding to the protein of interest
was processed for in-gel digestion at the UNMC proteomics
facility using the protocol of Shevchenko et al. (2006). Extracted
peptides were re-suspended in 2% acetonitrile (ACN) and 0.1%
formic acid (FA) and loaded onto trap column Acclaim PepMap
100 75µm× 2 cmC18 LCColumns (Thermo Fisher Scientific) at
flow rate of 4 µl/min. These were then separated with a Thermo
RSLC Ultimate 3000 (Thermo Fisher Scientific) on a Thermo
Easy-Spray PepMap RSLC C18 75 µm × 50 cm C-18 2 µm
column (Thermo Fisher Scientific) with a step gradient of 4–
25% solvent B (0.1% FA in 80% ACN) from 10 to 22 min and
25–35% solvent B for 22–32 min at 300 nL/min and 50◦C with a
70min total run time. Eluted peptides were analyzed by a Thermo
Orbitrap Fusion Lumos Tribrid (Thermo Fisher Scientific) mass
spectrometer in data dependent acquisition mode. A survey full
scan MS (from m/z 350–1800) was acquired in the Orbitrap with
a resolution of 120,000. The AGC target for MS1 was set as
4 × 105 and ion filling time set as 100 ms. The most intense ions
with charge state 2–6 were isolated in 3 s cycle and fragmented
using HCD fragmentation with 40% normalized collision energy
and detected at a mass resolution of 30,000 at 200 m/z. The AGC
target for MS/MS was set as 5× 104 and ion filling time set 60 ms
dynamic exclusion was set for 30 s with a 10 ppm mass window.
Protein identification was performed by searching MS/MS data
against the Swiss-Prot human protein database downloaded on
Aug 20, 2018. The search was set up for full tryptic peptides with
a maximum of two missed cleavage sites. Acetylation of protein
N-terminus and oxidized methionine were included as variable
modifications and carbamidomethylation of cysteine was set as
fixed modification. The precursor mass tolerance threshold was
set 10 ppm and maximum fragment mass error was 0.02 Da.
Qualitative analysis was performed using PEAKS 8.5 software.
The significance threshold of the ion score was calculated based
on a false discovery rate of ≤1%.
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RESULTS
In the process of flow cytometry panel validation, we
compared IL-4 expression among total CD4 T cells following
PMA/ionomycin stimulation using 5 separate monoclonal
antibodies: clones 8D4-8, MP4-25D2, 4D9, REA895, and
3010.211. Clones 4D9, REA895, 3010.211 and MP4-25D2
generated clean populations of IL-4 positive events that were
specific to PMA/ionomycin-stimulated cells and enriched in the
antigen-experienced CD45RA- subset (Figure 1). Alternatively,
clone 8D4-8 appeared somewhat less specific. Clone 8D4-8
uniquely bound a population of IL-4+ events in the absence
of PMA/ionomycin stimulation (Figure 1). Further analysis of
total PBL revealed that these events were both Live/Dead+/−
and significantly higher with 8D4-8 than with the remaining
clones (Figure 2). From these results, we concluded that 8D4-8
performed differently than the other clones. This led us to
wonder if a unique IL-4 isoform was actually detected by 8D4-8.
We then revised our flow cytometry panels to include 2
distinct IL-4 clones, or 8D4-8 with IFN-γ as a control. We
tested BV421-conjugated 8D4-8 paired with PE-conjugated 4D9,
REA895, MP4-25D2, or 3010.211, as well as with PE-conjugated
IFN-γ (clone 4S.B3). Interestingly, we observed each pair of anti-
IL-4 antibodies bound a double positive subset (Figure 3A).
However, clone 8D4-8 was the only antibody that bound a
clone-specific population (Figure 3A red arrows). The results
from these analyses indicate that 8D4-8 appears to bind similar
targets as the other 4 clones, yet is able to detect a unique
population of cells.
As alternate IL-4 isoforms have been previously described
but less well characterized, we sought to analyze lymphocyte
lysates by western blotting in order to determine which IL-
4 isoform may be detected by 8D4-8. Here, we compared
PMA/ionomycin-treated PBL with PBL given only PTIs. Probing
with 8D4-8, we observed a strong band around 17 kD associated
with PMA/ionomycin stimulation (Figure 3B). However, there
were no demonstrable bands less than 20 kD associated with
PTI treatment. Interestingly, both treatments generated bands
between 250 and 100 kD. Thus, we found no evidence for known
IL-4 isoforms, which should be lower molecular weight than
the canonical form.
Previous studies have demonstrated that IL-4 expression is
associated with apoptosis, and these studies share the usage of
8D4-8 (Ledru et al., 2003; Veenstra et al., 2008). We sought to
investigate this apoptosis-associated IL-4 and treated PBLs with
increasing concentrations of the apoptosis-inducer staurosporine
(Belmokhtar et al., 2001). We then evaluated IL-4 (8D4-8)
expression by flow cytometry. These cells were not given PTIs
as a previous report indicated this IL-4 variant is not secreted
(Ledru et al., 2003). We observed robust increases in 8D4-
8+ cells with increasing levels of staurosporine concentrations,
thus replicating previous work (Figures 4A,B). Irrespective of
treatments, 8D4-8+ cells were largely Live/Dead+ (Figure 4A).
Using this method as a way to enrich for IL-4 expression, we
then prepared lysates from staurosporine-treated and control
lymphocytes and compared them by western blot. We observed
substantial increases in high molecular weight bands (∼100 and
∼250 kD) with staurosporine treatment compared to control
(Figure 4C). These data matched what we observed with
staurosporine-treated cells using flow cytometry and 8D4-8.
Thus, we concluded that the additional protein detected by 8D4-8
was ∼100 kD or greater, well out of range for any known IL-
4 isoform.
To identify which protein 8D4-8 was binding, we performed
immunoprecipitations(IPs) on control or staurosporine-treated
lymphocytes. We then excised bands at ∼100 kD and identified
the proteins via mass spectrometry. Our data indicated both
control (data not shown) and staurosporine IPs (Figures 5A,B)
were enriched for a tail section of myosin-9 in the 100 kD
region. We then blotted IPs from control and staurosporine
treated cells with commercial antibodies specific to tail regions
of myosin-9. Anti-myosin-9 goat polyclonal antibody EB09020
was generated against the sequence DQINTDLNLERSH (aa
1760–1762), while anti-myosin 9 rabbit monoclonal antibody
EPR8965 was generated against a proprietary sequence between
aa 1900–2000 of full length myosin-9. Using these antibodies, we
observed strong bands at∼225 and∼95 kD with both antibodies
from both control (data not shown) and staurosporine-treated
lysates (Figure 6). These results demonstrated that 8D4-8
cross-reacts with myosin-9. It has been previously published
that the myosin-9 tail breaks away during apoptosis (Suarez-
Herta et al., 2000; Kato et al., 2005). Judging from our ability
to detect the ∼95 kD fragment in whole cell lysates and
following IP, it’s likely that 8D4-8 binds somewhere along
the tail region.
To follow up on these findings, we used immunofluoresence
to query coexpression of 8D4-8 and myosin-9. Using Caco-
2 cells, a colorectal adenocarcinoma cell line, we observed
broad specific myosin-9 expression with no 8D4-8 binding
in untreated cells (Figure 7A). Following overnight treatment
with staurosporine, the majority of adherent cells had exhibited
retracted processes and condensed cytoplasm yet no binding
of 8D4-8 (Figure 7B). Scattered throughout, in various
stages of disassociation, we found Caco-2 cells advanced
in apoptosis which exhibited striking 8D4-8 expression that
colocalized with myosin-9 (Figure 7C). This coexpression
was limited to cells with condensed or fragmented nuclei
(Figure 7C white arrows).
Finally, it’s been reported that myosin-9 is expressed externally
on the surface of apoptotic cells and can be detected with
anti-myosin-9 antibodies without cellular permeabilization (Chu
et al., 2010). We reasoned that since 8D4-8 detects myosin-9
associated with apoptosis, we should be able to detect 8D4-
8+, myosin-9+ (double-positive) events on non-permeabilized
lymphocytes. We then performed surface flow cytometry
using 8D4-8 and anti-myosin-9 antibodies to test this. As
previously reported, myosin-9 was found to be accessible without
permeabilization, and this was also the case for 8D4-8 (Figure 8).
In both staurosporine-treated and control PBL, these double-
positive events demonstrated somewhat linear expression levels.
Furthermore, we observed increased proportions of double-
positive events among staurosporine-treated PBL compared to
control. These observations provide further evidence of 8D4-8
binding myosin-9.
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FIGURE 1 | Anti-IL-4 clone 8D4-8 uniquely detects a population of events in the absence of PMA/ionomycin stimulation. CD4 T cells were identified as CD4+,
CD8−, CD3+, Live/Dead−, singlet events (not shown). Anti-IL-4 clones 8D4-8, 4D9, 3010.211, MP4-25D2, and REA895 identify comparably sized subsets among
CD45RA− CD4 T cells following PMA/ionomycin stimulation. However, clone 8D4-8 identifies a sizeable population of events (red box) following culture with only
brefeldin A and monensin (protein transport inhibitors, PTI). Isotype and fluorescence minus one (FMO) controls are shown at bottom for reference. Mouse IgG1 is
the isotype for 8D4-8, 4D9, and 3010.211, rat IgG1 is the isotype for MP4-25D2, and human IgG1 is the isotype for REA895. Data shown are representative from 3
experiments from 3 donors.
FIGURE 2 | Clone 8D4-8 expression is enriched among Live/Dead+ and Live/Dead− cells. PBL were pregated to remove doublets (not shown), and then examined
to compare IL-4 expression with Live/Dead following treatment with protein transport inhibitors (PTI). (A,B) Clone 8D4-8 uniquely detects a sizeable population
Live/Dead+ cells, as well as a subset of Live/Dead− events. In comparison, clones 4D9, 3010.211, REA895, and MP4-25D2 show negligible binding among
Live/Dead+/− events. Data shown are representative from 3 experiments from 3 donors. Bars represent mean values and standard deviation. Significance was
determined by ANOVA.
DISCUSSION
During the process of routine flow cytometry panel validation,
we observed unique behavior associated with a widely available
mouse monoclonal antibody targeting human IL-4, clone 8D4-8.
This is not the first report of such unique results using this
clone. From previously published literature, the application of
clone 8D4-8 in flow cytometry experiments can be divided into
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FIGURE 3 | Clone 8D4-8 detects IL-4, yet also identifies a unique target. CD45RA− CD4 T cells were identified as CD45RA−, CD4+, CD8−, CD3+, singlet events
(not shown). (A) When co-labeled with other IL-4 clones, 8D4-8 detects 2 populations of cells: one which is apparently IL-4 and another unknown target which is
limited to 8D4-8. Importantly, clones 4D9, 3010.211, REA895, and MP4-25D2 do not detect unique populations. 8D4-8 was also compared with IFN-γ as a control.
Data shown are representative of 3 separate experiment from 3 donors. (B) Western blotting of recombinant human IL-4 (rhIL-4), protein transport inhibitor
(PTI)-treated, and PMA/ionomycin with PTI− treated cell lysates demonstrate 8D4-8 is capable of detecting recombinant IL-4 as well as natural IL-4 (black arrow).
Multiple high molecular weight bands are present in both treatments. Western blot data are representative of 5 stimulations and experiments from 5 donors.
FIGURE 4 | Staurosporine treatment increases the expression of the 8D4-8 target. PBL were pregated to remove doublets (not shown). (A) Representative scatter
plots showing control and 1.25 µM staurosporine-treated PBL. Staurosporine-treated PBL show increased expression of the 8D4-8 target, and, just like in control,
these cells are mostly Live/Dead+. (B) Increasing concentrations of staurosporine induce the expression of the 8D4-8 target. In the graph, points are averages and
error bars represent standard deviation. For (A,B) data are representative of 3 experiments from 3 donors. (C) Western blotting of recombinant human IL-4 (rhIL-4),
control, and staurosporine-treated cell lysates demonstrate that the protein(s) upregulated by staurosporine treatment is of high molecular weight, with a major band
around 100 kD (black arrow). Western blot data are representative of 4 stimulations and experiments from 4 donors.
two groups: those cognizant of 8D4-8 detecting an apoptosis-
associated IL-4 and those unaware that 8D4-8 responds
uniquely among apoptotic cells. Among the former group, the
earliest reports demonstrated increased IL-4 expression following
various apoptosis inducers among human PBMC and several cell
lines (Stein et al., 2000a,b). The concept was further developed
with the report that the 8D4-8 target was not secreted and was
linked to a unique IL-4 mRNA missing 13 bp, dubbed IL-4δ13
(Ledru et al., 2003). Increased 8D4-8 expression among apoptotic
cells was also observed among all major classes of circulating
leukocytes (Veenstra et al., 2008), as well as among γδT cells
(Bhat et al., 2016). Additionally, elevated 8D4-8 expression was
associated with resting T cells of early childhood (Hebel et al.,
2014). Our results indicate that these studies were likely observing
myosin-9 rather than IL-4. Importantly, we were unable to
detect any bands in the range of purported IL-4 size with
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FIGURE 5 | Mass spectrometry showing identification of peptide and sequence coverage of myosin-9. Results from one mass spectrometry analysis of the ∼100 kD
band from an 8D4-8 immunoprecipitation of staurosporine-treated PBL. In total, 2 control and 2 staurosporine-treated samples were analyzed from 2 separate
experiments. (A) Identification of peptide representing sequence from 1194 to 1209 of myosin-9. (B) Sequence coverage (31%) of myosin-9.
FIGURE 6 | 8D4-8 immunoprecipitates myosin-9. We western blotted equal
volumes of 8D4-8 immunoprecipate and targeted with either (A) rabbit
monoclonal anti-myosin-9, or (B) goat polyclonal anti-myosin-9. Both
myosin-9 antibodies detected bands at ∼225 and ∼95 kD, in the size range
of full length myosin-9 as well as the apoptosis-associated tail piece. Data are
representative of 2 separate immunoprecipitations of control and
staurosporine-treated lysates which were used for mass spectrometry
analysis.
8D4-8 following staurosporine treatment. Rather, we observed
enriched abundance of a ∼100 kD target which was found
to be a chain of myosin-9 that was associated with apoptosis.
Colocalization immunofluorescence experiments indicated that
8D4-8 only significantly reacted with myosin-9 among apoptotic
cells, while dual surface labeling of 8D4-8 and myosin-9 on
staurosporine-treated cells demonstrated a high level of double
positive events. In total, we have found no evidence to support
the hypothesis that apoptotic cells produce substantial amounts
of IL-4 of any isoform.
The application of 8D4-8 in studies where users did not know
it bound a unique apoptosis-associated target presents a sizable
issue. In evaluating the literature for IL-4 expression measured
by flow cytometry in the time since the publication of 8D4-
8, we found multiple publications reported using this clone
(Prussin and Metcalfe, 1995; Fukui et al., 1997; Kallas et al.,
1998; Kon et al., 1998; Schulze-Koops et al., 1998; Furlan et al.,
2000; Kipp et al., 2000; Johansson-Lindbom and Borrebaeck,
2002; Rutella et al., 2002; Ryan et al., 2002; Sugimoto et al., 2002;
Walker et al., 2002; Hashizume et al., 2005; Kilani et al., 2005;
Nakamura et al., 2005; Acosta-Rodriguez et al., 2007; Ito et al.,
2008; Delgado et al., 2009; Godefroy et al., 2011; Saito et al.,
2011; Truchetet et al., 2011; Caccamo et al., 2012; Miguel et al.,
2012; Baeck et al., 2013; LaVoy et al., 2013; Myklebust et al.,
2013; Qiu et al., 2013; Jergovi et al., 2014; Mattoo et al., 2014;
Periolo et al., 2014; MacDonald et al., 2015; Wang S. et al., 2015;
Wang Z. et al., 2015; Coraglia et al., 2016; De Biasi et al., 2016; Li
et al., 2016; Vacaflores et al., 2016; Wang et al., 2016; Hou et al.,
2017; Powell et al., 2017; Rouxel et al., 2017; Fox et al., 2018;
Kim et al., 2018; Kwok et al., 2018; Maselli et al., 2018; Rotolo
et al., 2018; Sureshchandra et al., 2018;Mann et al., 2019; Schreurs
et al., 2019). This list should not be considered exhaustive as some
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 April 2019 | Volume 7 | Article 46
Harms et al. 8D4-8 Cross-Reacts With Myosin-9
FIGURE 7 | 8D4-8 and myosin-9 colocalize among apoptotic cells. (A) We observed no detectable 8D4-8 expression among healthy control Caco-2 cells. (B) The
majority of staurosporine-treated Caco-2 cells show retracted processes and more condensed cytoplasm, but do not bind 8D4-8. (C) Scattered among the
staurosporine-treated cells were 8D4-8+ cells. These cells were limited to those in apparent apoptosis. Note the condensed chromatin (white arrows) associated
with the 8D4-8+ cells. For (A–C), blue is DAPI, red is myosin-9, and green is 8D4-8. Images were acquired at 200× magnification. Results are representative of 3
experiments.
FIGURE 8 | Surface detection of 8D4-8 and myosin-9 colabels a population of increased size following staurosporine treatment. PBL were pregated to remove
doublets (not shown). Cellular permeabilization is not required to detect 8D4-8 and myosin-9 among control or staurosporine-treated PBL. Results are representative
of 3 experiments from 3 donors.
publications may have been missed and many reports evaluating
IL-4 did notmention which clone was used. Regarding the known
literature for 8D4-8 detecting canonical IL-4 expression, it must
be reevaluated carefully. While our data indicate that 8D4-8 can
truly bind IL-4, this can only be completely confirmed in flow
cytometry by using an additional unique clone, an approach
which is rarely taken. Furthermore, our data indicate that even
the use of a dead cell discriminator will not completely eliminate
myosin-9 binding from an 8D4-8 experiment. Finally, the ability
for 8D4-8 to bind apoptotic, resting targets both intracellularly
and on the cellular surface presents grave technical obstacles as
“IL-4+” cells can be measured in the absence of proper cellular
activation or functional cellular permeabilization. Thus, in total,
we conclude that 8D4-8 should not be used in flow cytometric
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applications interrogating IL-4 expression. In our hands, clones
4D9 and REA895 were the best choices for IL-4 expression
experiments, although clones MP4-25D2 and 3010.211 were
acceptable. While untested here, clone 8D4-8 may still be suitable
for IL-4 ELISA and ELISpot, and can be used with caution in
western blotting. Alternatively, it could be repurposed to evaluate
myosin-9 breakdown in apoptotic cells.
Being beyond the scope of our goal of panel and antibody
validation, the mechanism behind 8D4-8 binding myosin-9
remains unresolved. We observed functional binding of 8D4-8
in several scenarios: (1) reducing and non-reducing (data not
shown) denaturing conditions, (2) following formalin fixation,
(3) and on unfixed cells. In total, these results suggest an exposed
linear epitope becomes available as cells progress through the
stages of apoptosis. Previous work on myosin-9 degradation
associated with apoptosis demonstrated two cleavage sites at Asp-
1153 and Asp-1948 resulting in a 95 kD fragment (Kato et al.,
2005). In sequence aligning of IL-4 and myosin-9 aa 1153–1948,
we observed a handful of similarities which could be binding
regions for 8D4-8 (data not shown). However, epitope mapping
within this region should be performed to properly define the
binding sequence.
In conclusion, the process of flow cytometry panel validation
requires multiple steps in order to generate successful assays
(Mahnke and Roederer, 2007). Being (generally) an antibody-
based approach, the assessment of antibody specificity must be
included in the validation process as well. While this increases
panel validation time and cost, the outcome of comparing
the performance of a handful of clones is confidence in the
reproducibility and integrity of the assay – certainly worthy
recompense. Of course, this is not a novel suggestion. The
problems of antibody specificity, validation, and the associated
“reproducibility crisis” have been on display for some time (Saper,
2009; Voskuil, 2014; Baker, 2015; Weller, 2016). The methods to
correct these problems are not infeasible, they just require their
incorporation into all optimization workflows.
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